VIYASHNSEViyash Scientific LimitedLowNeutral
Announced Fri, 13 Mar · 19:44 IST

Viyash Scientific Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.

Board & Shareholder Meetings View source PDF

VIYASH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.7%1-day move
₹196.32
prior close
₹196.65
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.5-0.4+0.1+0.8-2.7-0.6-3.7-3.7-8.0-0.7+4.7+5.4+15.4+26.0
Up moveDown movePending
AI summary

Viyash Scientific Limited has announced the results of its Postal Ballot, with all four special resolutions passed by shareholders with the required majority. The resolutions cover: (1) the appointment of Dr. Haribabu Bodepudi as Managing Director and Group CEO for two years (97.32% in favour), (2) grant of stock options exceeding 1% of issued capital to an identified employee (97.32% in favour), (3) appointment of Mr. Rajaram Narayanan as Whole-time Director (98.83% in favour), and (4) appointment of Mr. Srinivas Vasireddy as Whole-time Director (Executive) for two years (98.64% in favour). Voting was conducted via remote e-voting from February 11, 2026 to March 12, 2026, and the results were declared on March 13, 2026. Promoters (holding 26.78 crore shares) voted 100% in favour of all resolutions. Institutional investors showed notable dissent on resolutions 1 and 2 (around 25% against), but public non-institutional investors overwhelmingly supported all four resolutions.

Likely market impact

Shareholders have formally approved key leadership appointments and a significant ESOP grant, giving the board clarity to proceed with the new management structure. The strong approval margins (over 97% on all resolutions) signal broad investor confidence, though the meaningful institutional dissent on stock options (around 25%) may warrant attention. Overall, this is a routine governance clearance with no material impact on the stock price expected.